KNOXVILLE, Tenn., Dec. 18, 2006 (PRIME NEWSWIRE) -- Craig Dees, CEO, of Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), will be featured live on Market News First (www.MN1.com) for an exclusive interview with the MN1 news team. The interview is scheduled for Dec. 19, 2006, at 10:00AM CDT.
About Provectus Pharmaceuticals Inc.
Provectus Pharmaceuticals, Inc. is a pioneering pharmaceutical company actively engaged in the design and development of pharmaceutical technologies for the treatment of metastatic melanoma, breast cancer and liver cancer. In addition, Provectus is preparing to begin Phase 2 clinical studies for the Company's topical agent Xantryl for psoriasis. Join Craig Dees to learn more about the goals of the company, as well as its position in the stock market.
About MN1.com
Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live radio web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.
Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies' present condition and future plans.
Stay up to date with MN1 NewsWire "NEWS YOU CAN TRUST" at www.MN1.com .